BII Biocompatibles

 
TIDMBII TIDMBGC 
 
Disclosure under Rule 2.11d of The Takeover Code 
 
Aberforth Partners LLP ("Aberforth") provided a non-binding letter of intent to 
BTG plc regarding BTG plc's proposed acquisition of Biocompatibles 
International plc ("Biocompatibles"), as referred to in the announcement of the 
acquisition dated 19 November 2010. On 13 December 2010, Aberforth disposed of 
65,500 shares (over which it had voting authority) in Biocompatibles, on behalf 
of clients. As a result, Aberforth now intends to vote in favour of the 
resolutions to be proposed at the Court Meeting and the Biocompatibles general 
meeting necessary to approve the Scheme (or as the case may be, to accept the 
Takeover Offer) in respect of 3,574,582 Biocompatibles shares, over which it 
has voting authority. 
 
Date: 14 December 2010 
 
Contact: Pauline Robson, for Aberforth Partners LLP 
 
Telephone: 0131 220 0733 
 
 
 
END 
 

Biocompatibles (LSE:BII)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Biocompatibles (LSE:BII)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024